Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sarepta Therapeutics

62.40
+1.552.55%
Pre-market: 62.870.4700+0.75%09:09 EDT
Volume:1.58M
Turnover:97.40M
Market Cap:6.13B
PE:26.69
High:62.51
Open:59.98
Low:59.62
Close:60.85
Loading ...

H.C. Wainwright sees increased uncertainty for Sarepta franchise

TIPRANKS
·
04 Apr

SRPT Stock Down After EMA Places Clinical Hold on DMD Gene Therapy

Zacks
·
04 Apr

Oppenheimer healthcare analysts hold analyst/industry conference call

TIPRANKS
·
04 Apr

Sarepta Shares Fall After EMA Reportedly Places Hold on Elevidys Trial Enrollment for Duchenne Muscular Dystrophy

MT Newswires Live
·
04 Apr

TD Cowen Reaffirms Their Buy Rating on Sarepta Therapeutics (SRPT)

TIPRANKS
·
03 Apr

Deutsche Bank Adjusts Sarepta Therapeutics Price Target to $70 From $99, Maintains Hold Rating

MT Newswires Live
·
03 Apr

Sarepta Therapeutics Inc : Needham Cuts Target Price to $183 From $202

THOMSON REUTERS
·
03 Apr

Sarepta Therapeutics Is Maintained at Buy by Needham

Dow Jones
·
03 Apr

Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

StockStory
·
03 Apr

Could The Market Be Wrong About Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Given Its Attractive Financial Prospects?

Simply Wall St.
·
03 Apr

Sarepta Therapeutics Shares Rise After HC Wainwright Upgrade

MT Newswires Live
·
03 Apr

BUZZ-Sarepta Therapeutics up after H.C. Wainwright upgrade

Reuters
·
03 Apr

Top Calls on Wall Street: Broadcom, Strategy, Snowflake, United Airlines, Paramount, nCino, and More

The Fly
·
02 Apr

Sarepta Therapeutics Raised to Neutral From Sell by HC Wainwright & Co.

Dow Jones
·
02 Apr

HC Wainwright Upgrades Sarepta Therapeutics to Neutral From Sell, Price Target is $75

MT Newswires Live
·
02 Apr

Sarepta upgraded to Neutral from Sell at H.C. Wainwright

TIPRANKS
·
02 Apr

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks
·
01 Apr

Sarepta Therapeutics Inc : Bofa Global Research Cuts Price Objective to $179 From $210

THOMSON REUTERS
·
01 Apr

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
01 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Veritex, Gaming and Leisure Properties, Apple

Reuters
·
01 Apr